Healthcare provider profile · identity verified

Richard E Musser, D.O.

Family Practice · DONIPHAN, MO · NPI 1366407835

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	541	54
Alprazolam	Alprazolam	475	47
Gabapentin	Gabapentin	289	33
Tizanidine Hcl	Tizanidine Hcl	222	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	216	35
Albuterol Sulfate Hfa	Albuterol Sulfate	193	33
Ibuprofen	Ibuprofen	171	21
Omeprazole	Omeprazole	162	27
Tramadol Hcl	Tramadol Hcl	152	22
Furosemide	Furosemide	138	22
Potassium Chloride	Potassium Chloride	137	16
Diazepam	Diazepam	129	12
Atenolol	Atenolol	127	17
Clonazepam	Clonazepam	121	15
Lisinopril	Lisinopril	121	16
Atorvastatin Calcium	Atorvastatin Calcium	117	18
Metoprolol Tartrate	Metoprolol Tartrate	114	15
Meloxicam	Meloxicam	104	16
Citalopram Hbr	Citalopram Hydrobromide	102	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	102	15
Zolpidem Tartrate	Zolpidem Tartrate	101	suppressed
Famotidine	Famotidine	90	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	87	11
Ventolin Hfa	Albuterol Sulfate	83	14
Amlodipine Besylate	Amlodipine Besylate	81	11
Metformin Hcl	Metformin Hcl	81	12
Estradiol	Estradiol	80	11
Amitriptyline Hcl	Amitriptyline Hcl	79	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	73	34
Losartan Potassium	Losartan Potassium	73	12
Trazodone Hcl	Trazodone Hcl	72	suppressed
Ondansetron Hcl	Ondansetron Hcl	71	13
Fluoxetine Hcl	Fluoxetine Hcl	68	suppressed
Metoprolol Succinate	Metoprolol Succinate	64	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	63	47
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	61	13
Dicyclomine Hcl	Dicyclomine Hcl	58	suppressed
Simvastatin	Simvastatin	56	suppressed
Clopidogrel	Clopidogrel Bisulfate	55	suppressed
Duloxetine Hcl	Duloxetine Hcl	53	suppressed
Prednisone	Prednisone	52	suppressed
Carvedilol	Carvedilol	50	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	49	suppressed
Clonidine Hcl	Clonidine Hcl	48	suppressed
Azithromycin	Azithromycin	45	27
Escitalopram Oxalate	Escitalopram Oxalate	44	suppressed
Ondansetron Odt	Ondansetron	40	suppressed
Symbicort	Budesonide/Formoterol Fumarate	38	suppressed
Testosterone Cypionate	Testosterone Cypionate	38	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	36	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Xarelto	Rivaroxaban	34	suppressed
Pregabalin	Pregabalin	33	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	32	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Eliquis	Apixaban	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Aripiprazole	Aripiprazole	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Sucralfate	Sucralfate	26	suppressed
Methylprednisolone	Methylprednisolone	24	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	23	suppressed
Fluconazole	Fluconazole	23	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	23	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	23	suppressed
Nitroglycerin	Nitroglycerin	23	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	22	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	21	21
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Glimepiride	Glimepiride	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	11
Twinrix	Hepatitis A And B Vaccine/Pf	18	17
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Pentoxifylline	Pentoxifylline	17	suppressed
Sertraline Hcl	Sertraline Hcl	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Glipizide	Glipizide	14	suppressed
Linzess	Linaclotide	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Trintellix	Vortioxetine Hydrobromide	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error